Preclinical Appraisal of Hematinic Potential of Mandura Bhasma for Treating Anemia
Deepak S. Khobragade
Datta Meghe College of Pharmacy, Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi(M), Wardha, Maharashtra, India.
Mrunali S. Potbhare *
GITAM Institute of Pharmacy, Vizag, Andhra Pradesh, India.
Awdhut Pimpale
Datta Meghe College of Pharmacy, Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi(M), Wardha, Maharashtra, India.
Sagar B. Wankhede
Datta Meghe College of Pharmacy, Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi(M), Wardha, Maharashtra, India.
Chandrashekhar R. Tempe
Government College of Pharmacy, Amravati, Maharashtra, India.
*Author to whom correspondence should be addressed.
Abstract
Aims: To evaluate hematinic potential of mandura bhasma.
Study Design: Experimental study.
Place and Duration of Study: Institute of Pharmaceutical Education and Research, Wardha, Maharashtra, India. 6 Months.
Methodology: The anti-anaemic potential of Mandura bhasma in Wistar rats was investigated. Anaemia was induced in rats with phenyl hydrazine hydrochloride at a dose of 10 mg kg-1 body weight by oral administration. Anaemia was treated with mandura bhasma administered in three different doses based on body weight.
Results: In vivo investigation showed that though the dose of 6mg kg-1 body weight of mandura bhasm produced only a minimal antianaemic (hematinic) effect, oral daily dose of 11 mg kg-1 body weight and 22mg kg-1 body weight a produced a significant (P < 0.05) antianaemic effect when compared to standard drug ferrous sulphate indicating dose dependent activity.
Conclusions: The results indicate that Mandura Bhasm have very potential dose dependant hematinic activity and can be a safe and effective drug for treating anemia.
Keywords: Anaemia, haematinic activity, mandura bhasma, phenyl hydrazine, ferrous sulphate